Making drug design second nature

Nature Chemistry

Volumn 1, Issue 8, 2009, Pages 596-597

  Sackett, Dan L ^a   Sept, David ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; TUBULIN;

BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; METABOLISM; NOTE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE;

ANTIMITOTIC AGENTS; BINDING SITES; DRUG DESIGN; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; TUBULIN;

EID: 70350444513     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.427     Document Type: Short Survey

References (9)

1. Fletcher, S. & Hamilton, A. D. Curr. Top. Med. Chem. 7, 922-927 (2007).
2. Robinson, J. A., Demarco, S., Gombert, F., Moehle, K. & Obrecht, D. Drug Discov. Today. 13, 944-951(2008).
3. Pieraccini, S. et al. Nature Chem. 1, 642-648 (2009).
4. Banerjee, S., Wang, Z., Mohammad, M., Sarkar, F. H. & Mohammad, R. M. J. Nat. Prod. 71, 492-496 (2008).
5. Rubinstein, M. & Niv, M. Y. Biopolymers 91, 505-513 (2009).
6. Ofran, Y. & Rost, B. PLoS Comput. Biol. 3, 1169-1176 (2007).
7. Zhong, S., Macias, A. T. & MacKerell, A. D. Jr Curr. Top. Med. Chem. 7 63-82 (2007).
8. González-Ruiz, D. & Gohlke, H. Curr. Med. Chem. 13, 2607-2625 (2006).
9. Che, Y., Brooks, B. R. & Marshall, G. R. J. Comput. Aided Mol. Des. 20, 109-130 (2006).